News | PACS | June 23, 2017

Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials

France-based organization to tap into Medidata platform that analyzes, captures and manages medical images to accelerate the development of new medicines in oncology

June 23, 2017 — Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.

Imaging technologies are a major part of evaluating new patient treatments, allowing clinicians and sponsors to detect diseases, monitor outcomes and determine therapy responses. Median Technologies, a services provider of image interpretation and management in oncology trials, will leverage Medidata Medical Imaging to transition its legacy imaging study management systems to a single digital environment, gaining seamless access to configurable and intelligent image workflows, while still maintaining global regulatory standards.

"Our collaboration with Medidata will not only ease the management of images during clinical drug trials- it will enhance our analytical rigor, enabling our teams to extract high-quality imaging biomarkers for better study and patient outcomes," said Jeanne Hecht, Median Technologies' chief operating officer.

Medidata Medical Imaging provides superior workflow management and flexibility of image resources, according to the company, working seamlessly with proprietary technologies like Median. The collaboration will provide Median with the highest level of control and access to image data and performance metrics, while enabling automatic edit checks and de-identification.

For more information: www.mdsol.com

Related Content

Sponsored Content | Videos | PACS | June 29, 2020
Kevin Borden, Vice President of Product, Healthcare IT for Konica Minolta, talks about Improving Access and Aiding Wo
News | Proton Therapy | June 16, 2020
June 17, 2020 — RaySearch Laboratories AB launched the latest release of its widely adopted treatment planning system
Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed this year by the American Society of Radiologic Technologists. Researchers noted, however, the survey data was collected before the COVID-19 pandemic began affecting the surveyed clinical settings.

Getty Images

News | Radiation Therapy | June 05, 2020
June 5, 2020 — Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed
MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

 

News | Radiation Therapy | June 01, 2020
June 1, 2020 — RefleXion Medical, a therape
In April, the U.S. Food and Drug Administration (FDA) cleared Intelerad’s InteleConnect EV solution for diagnostic image review on a range of mobile devices.
Feature | PACS | May 27, 2020 | By Melinda Taschetta-Millane
Fast, easily accessible patient images are crucial in this day and age, as imaging and medical records take on a new
Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut